Covid 19 resurges in the country: How THIS common symptom is key to the new variant
The COVID-19 virus has made a comeback after a lull of a couple of years, and there has been a surge in the number of cases worldwide, including India. For now, most cases remain mild, and patients are recovering well at home, though the government has issued caution for those who are suffering from co-morbidities, including pregnant women, and elderly people.
Tired of too many ads? go ad free now
However, the COVID-19 virus continues to change and mutate, creating new variants that spread differently and cause different symptoms. One of the newest variants, called NB.1.8.1 or "Nimbus," has caught the attention of doctors and patients worldwide because it often causes a very painful sore throat, also called "razor blade throat." Let's dig deeper into the new symptom...
History of the Nimbus variant
Nimbus (NB.1.8.1) is a descendant of the Omicron variant, and was first detected in January 2025.
Since then, it has spread quickly across many countries, including the United States, Canada, the United Kingdom, India, and parts of Asia. However, according to the World Health Organization (WHO) the variant remains mild as of now, and does not cause severe illness.
Why Is Throat Pain So Common with Nimbus
Doctors have noticed that many patients infected with Nimbus report a sore throat that feels extremely painful, to the extent that even drinking water feels difficult.
Some describe it as if they are "swallowing razor blades" or "glass." This is different from the mild sore throat people experienced with earlier COVID variants.
Leading doctors explain that in this symptom, the throat feels very dry and cracked, causing intense pain. This severe throat pain likely happens because the virus causes inflammation and irritation in the throat tissues, leading to pain that can exacerbate while eating and drinking.
Tired of too many ads? go ad free now
Other symptoms
Though throat pain is the new symptom of the Nimbus variant, it usually comes with other common COVID symptoms. These include:
Cough
Fever
Fatigue
Muscle aches that feel like extreme fatigue and tiredness
Nasal congestion that can last longer than usual
Headaches
Nausea or vomiting
Changes in taste or smell
These symptoms are similar to those seen with other Omicron variants as well.
What should you do if you have a sore throat
Not all sore throats will be caused by Covid. However, if you are experiencing other symptoms as well, along with a sore throat that feels sharp or burning, especially if it is severe enough to make swallowing difficult, you should:
Get tested for COVID-19: Since throat pain is a key symptom of the Nimbus variant, testing can confirm if you have the virus.
Stay isolated: To prevent spreading the virus to others, stay home and avoid close contact with people.
Drink plenty of fluids: Even if it hurts, try to keep yourself hydrated to soothe your throat.
Use throat lozenges or warm salt water gargles: These can help ease the pain temporarily.
Seek medical help if symptoms worsen: If you have trouble breathing, persistent high fever, or severe pain, contact a healthcare provider immediately.
Remember, sore throats can also be caused by a bacterial infection that can only be managed with antibiotics. However, since Covid is a virus, it does not respond to antibiotics. Hence, it is important to not self medicate, and consult a doctor.
Vaccine is still your best bet
The good news is that current COVID-19 vaccines, especially with updated boosters, continue to protect people from severe disease, hospitalization, and death caused by the Nimbus variant. While the variant can cause painful symptoms like sore throat, vaccinated individuals generally experience milder illness.
Sources: World Health Organization, the Centers for Disease Control and Prevention
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
It's not just 'chronic fatigue': ME/CFS much more than being tired
Melbourne: Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is as complex as its name is difficult to pronounce. It's sometimes referred to as simply "chronic fatigue", but this is just one of its symptoms. In fact, ME/CFS is a complex neurological disease, recognised by the World Health Organization, that affects nearly every system in the body. The name refers to muscle pain (myalgia), inflammation of the brain (encephalomyelitis), and a profound, disabling fatigue that rest can't relieve. However, the illness's complexity - and its disproportionate impact on women - means ME/CFS has often been incorrectly labelled as a psychological disorder. What is ME/CFS? ME/CFS affects people of all ages but is most commonly diagnosed in middle age. It is two to three times more common in women than men. While the exact cause is unknown, ME/CFS is commonly triggered by an infection. The condition has two core symptoms: a disabling, long-lasting fatigue that rest doesn't relieve, and a worsening of symptoms after physical or mental exertion. This is known as post-exertional malaise . It means even slight exertion can make symptoms much worse, and take much longer than expected to recover. This varies between people, but could mean simply having a shower or attending a social event triggers worse symptoms, either immediately or days later. These symptoms include pain, sleep issues, cognitive difficulties (such as thinking, memory and decision-making), flu-like symptoms, dizziness, gastrointestinal problems, heart rate fluctuations and many more. For some people, symptoms can be managed in a way that allows them to work. For others, the disease is so severe it can leave them housebound or bedridden. Symptoms can fluctuate, changing over time and in intensity, making ME/CFS a particularly unpredictable and misunderstood condition. Not just 'in your head' A growing body of scientific evidence, however, clearly shows ME/CFS is a biological, not mental, illness. Neuroimaging studies have revealed differences in the brain activity and structure of people with ME/CFS, including poor blood flow and lower levels of neurotransmitters (chemical messengers in the nervous system). Other research indicates the condition affects how the body produces energy (the metabolism), fights infection (the immune system), delivers oxygen to muscles and tissues, and regulates blood pressure and heart rate (the vascular system). Issues with criteria To diagnose ME/CFS, a clinician will also exclude other possible causes of fatigue, which can be a lengthy process. A patient needs to meet a set of clinical criteria. But one of the major challenges in researching ME/CFS is that the diagnostic criteria clinicians use vary worldwide. Some criteria focus solely on fatigue and include people with alternate reasons for fatigue, such as a psychiatric disorder. Others are more narrow and may only capture ME/CFS patients with more severe symptoms. As a result, it can be very difficult to compare across different studies, as the reasons they include or exclude participants vary so much. Changes to the guidelines In Australia, doctors often receive little formal education about ME/CFS. Most commonly, they follow the Royal Australian College of General Practitioners' clinical guidelines to diagnose and manage ME/CFS. These are based on the Canadian Consensus Criteria which are considered more stringent than other ME/CFS diagnostic criteria. They include post-exertional malaise and fatigue for more than six months as core symptoms. However, these guidelines are outdated and rely heavily on controversial studies that assumed the primary cause of ME/CFS was "deconditioning" - a loss of physical strength due to a fear or avoidance of exercise. These guidelines recommend ME/CFS should be treated with cognitive behavioural therapy - a common psychotherapy which focuses on changing unhealthy thoughts and behaviours - and graded exercise therapy, which gradually introduces more demanding physical activity. While cognitive behaviour therapy can be effective for some people managing ME/CFS, it's important not to frame this condition primarily as a psychological issue. Graded exercise therapy can encourage people to push beyond their " energy envelope ", which means they do more than their body can manage. This can trigger post-exertional malaise and a worsening of symptoms. In June 2024, the Australian government announced A$1.1 million towards developing new clinical guidelines for diagnosing and managing ME/CFS. Leading organisations have scrapped the recommendation of graded exercise therapy in the United States (in 2015) and the United Kingdom (in 2021). Hopefully Australia will follow suit. What can people with ME/CFS do? While we wait for updated clinical guidelines, "pacing" - or working within your energy envelope - has shown some success in managing symptoms. This means monitoring and limiting how much energy you expend. Some evidence also suggests people who rest in the early stages of their initial illness often experience better long-term outcomes with ME/CFS. This is especially relevant after the COVID pandemic and with the emergence of long COVID. Studies indicate more than half of those affected meet stringent clinical criteria for ME/CFS. In times of acute illness we should resist the temptation to push through. Choosing to rest may be a crucial step in preventing a condition that is much more debilitating than the original infection. (The Conversation)
Economic Times
2 hours ago
- Economic Times
Amazon, not the first, nor the last to attempt disruption. 5 diagnostics stocks: From downside forecast, to upside as high as 67%
Just a couple of weeks back, there were headlines about rising Covid cases in Southeast Asian countries. And alarm bells started ringing in India. Almost in step with this development, a domestic diagnostic stock again came into the limelight, with some reports mentioning how the company is getting ready for another surge in Covid. Fortunately, there was no surge of cases in India. And there certainly was no panic. So, it is probably good that FONT SIZE SAVE PRINT COMMENT
Time of India
2 hours ago
- Time of India
BHU anaesthesiologist Dr Dubey felicitated at Bharat-Bhutan Friendship Summit
VARANASI: Dr Rajeev Kumar Dubey, Professor of Anaesthesiology at Banaras Hindu University , was conferred the prestigious Vishisht Chikitsa Seva Ratna Award during the South Asian Excellence Awards programme held as part of the 6th Bharat-Bhutan Friendship Summit in Thimphu on Sunday. The award was presented by Daso Birendra Chimoria, Member of the National Assembly of Bhutan, and Tashi Tenzin, Officiating Director of the Tourism Council of Bhutan, in the presence of dignitaries from India and Bhutan. Dr Dubey, a renowned physician, author, and social influencer, received the award in recognition of his distinguished services in the field of medicine, especially for his dedication during the COVID-19 pandemic and his contributions to public health and medical education. Expressing his gratitude, Dr Dubey stated, 'This honour reflects the collective spirit of healthcare professionals and their commitment to humanity.'
